These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5885206)

  • 21. Changing prospects for children with hemophilia.
    Brinkhous KM
    Children; 1970; 17(6):222-7. PubMed ID: 5497215
    [No Abstract]   [Full Text] [Related]  

  • 22. Current status and trends in the treatment of hemophilic patients with inhibitors.
    Bloom AL
    Prog Clin Biol Res; 1981; 72():123-38. PubMed ID: 6801682
    [No Abstract]   [Full Text] [Related]  

  • 23. A hemophilia home care program utilizing cryoprecipitate.
    Shanberge JN; Kratz NL; Aster RH
    Scand J Haematol Suppl; 1977; 30():85-6. PubMed ID: 267309
    [No Abstract]   [Full Text] [Related]  

  • 24. Prophylactic therapy in classical hemophilia: a preliminary report.
    Robinson PM; Tittley P; Smiley RK
    Can Med Assoc J; 1967 Sep; 97(11):559-61. PubMed ID: 6050888
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic value of cryoprecipitate in hemophilia A].
    Lopaciuk S; Szczepański M; Klenowska Z; Daszyński J; Pawelski S
    Pol Tyg Lek; 1969 Jun; 24(22):829-32. PubMed ID: 4895749
    [No Abstract]   [Full Text] [Related]  

  • 26. [Substitution therapy of hemophilia A].
    Vlcková M
    Vnitr Lek; 1979 Mar; 25(3):295-300. PubMed ID: 433175
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of animal AHG concentrates (factor VIII) in the treatment of life-threatening hemorrhage in patients with factor VIII antibodies.
    Rubin R; Niemetz J; Estren S
    Ann N Y Acad Sci; 1975 Jan; 240():362-9. PubMed ID: 1053881
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemophilia management in transfusion medicine.
    Poon MC; Card R
    Transfus Apher Sci; 2012 Jun; 46(3):299-307. PubMed ID: 22503305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization of the residual plasma following preparation of factor VIII cryoprecipitate.
    Oberman HA; Penner JA
    JAMA; 1968 Sep; 205(12):819-21. PubMed ID: 5695503
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of haemophilia.
    Br Med J; 1967 Apr; 2(5544):65-6. PubMed ID: 6020849
    [No Abstract]   [Full Text] [Related]  

  • 31. [Present possibilities in the treatment of hemophilia with the available inhibitors].
    Haracić M; Kamhi J; Kurto J
    Med Arh; 1983; 37(4):175-80. PubMed ID: 6443876
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemofil and other factor VIII concentrates.
    Med Lett Drugs Ther; 1969 Nov; 11(23):96. PubMed ID: 5375104
    [No Abstract]   [Full Text] [Related]  

  • 33. Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors.
    Ehrenforth S; Kreuz W; Funk M; Auerswald G; Scharrer I
    Thromb Haemost; 1994 Nov; 72(5):784-5. PubMed ID: 7900088
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of hemophilia].
    Stavem P; Hjort PF
    Tidsskr Nor Laegeforen; 1970 Jul; 90(13):1413-8. PubMed ID: 5453192
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnosis and treatment of the hemophilias.
    Levin J
    Md State Med J; 1968 Sep; 17(9):75-7. PubMed ID: 5681701
    [No Abstract]   [Full Text] [Related]  

  • 36. Physiologic basis of transfusion therapy in hemophilia.
    BRINKHOUS KM; PENICK GD; LANGDELL RD; WAGNER RH; GRAHAM JB
    AMA Arch Pathol; 1956 Jan; 61(1):6-10. PubMed ID: 13275197
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effect of antihemophilic globulin in hemophilia].
    BREDDIN K; ROTTGER K
    Klin Wochenschr; 1954 Sep; 32(33-34):810-1. PubMed ID: 13202416
    [No Abstract]   [Full Text] [Related]  

  • 38. Purification and clinical evaluation of a factor 8 concentrate.
    Johnson AJ; Karpatkin MH; Newman J
    Bibl Haematol; 1970; 34():30-9. PubMed ID: 5436351
    [No Abstract]   [Full Text] [Related]  

  • 39. World use of blood products for hemophilia.
    Aledort LM
    Scand J Haematol Suppl; 1977; 30():56-7. PubMed ID: 267299
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapy for AHF and PTC hemophilia. I.
    Seeler RA
    IMJ Ill Med J; 1970 May; 137(5):518-21. PubMed ID: 4392774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.